XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.
Aufderklamm S, Hennenlotter J, Todenhoefer T, Gakis G, Schilling D, Vogel U, Kuehs U, Dlugosch J, Knapp J, Merseburger A, Gerber V, Ordelheide A, Hevler J, Stenzl A, Schwentner C.
Aufderklamm S, et al. Among authors: schilling d.
World J Urol. 2012 Aug;30(4):547-52. doi: 10.1007/s00345-011-0768-y. Epub 2011 Oct 4.
World J Urol. 2012.
PMID: 21969130